A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma

Summary

The purpose of this study is to determine whether ramucirumab is effective treatment in participants with metastatic renal cell carcinoma who have developed progressive disease or become intolerant to tyrosine kinase inhibitor therapy.

Timeline

Start

2007-11

Primary completion

2011-05

Completion

2011-05

Drugs

Indications